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1  | BACKGROUND
Mortality is a basic indicator of health, and monitoring of mortality is 
fundamental for health planning, risk assessment and public health 
action. There is a demand for standardised robust and comparable 
estimates to identify changes in mortality patterns in a timely or near 
real- time manner to assess and react on changes.
In temperate zones, all- cause mortality exhibits a marked sea-
sonality with the highest number of deaths in the winter. Many fac-
tors may contribute to seasonality, including acute respiratory tract 
infections and death from cardio- vascular diseases in the winter, a 
direct impact of periods with extreme temperature, and possibly 
mental and physiological effects (eg D- vitamin) related to absence 
of daylight in winter, as well as social and psychological factors 
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Background: In temperate zones, all- cause mortality exhibits a marked seasonality, 
and influenza represents a major cause of winter excess mortality. We present a sta-
tistical model, FluMOMO, which estimate influenza- associated mortality from all- 
cause mortality data and apply it to Danish data from 2010/11 to 2016/17.
Methods: We applied a multivariable time series model with all- cause mortality as 
outcome, influenza activity and extreme temperatures as explanatory variables while 
adjusting for time trend and seasonality. Three indicators of weekly influenza activity 
(IA) were explored: percentage of consultations for influenza- like illness (ILI) at pri-
mary health care, national percentage of influenza- positive samples, and the product 
of ILI percentage and percentage of influenza- positive specimens in a given week, 
that is, the Goldstein index.
Results: Independent of the choice of parameter to represent influenza activity, the 
estimated influenza- associated mortality showed similar patterns with the Goldstein 
index being the most conservative. Over the 7 winter seasons, the median influenza- 
associated mortality per 100 000 population was 17.6 (range: 0.0- 36.8), 14.1 (0.3- 
31.6) and 8.3 (0.0- 25.0) for the 3 indicators, respectively, for all ages.
Conclusion: The FluMOMO model fitted the Danish data well and has the potential 
to estimate all- cause influenza- associated mortality in near real time and could be 
used as a standardised method in other countries. We recommend using the Goldstein 
index as the influenza activity indicator in the FluMOMO model. Further work is 
needed to improve the interpretation of the estimated effects.
K E Y W O R D S
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related to Christmas and New Year holidays1. However, influenza is 
recognised as one of the main contributing factors of winter excess 
mortality.
A common method to assess winter excess mortality estimates, 
based on predefined periods with no or ignorable influenza activ-
ity, is by using the Serfling method2,3. The baseline for the Serfling 
model, which is usually fitted with a cyclic variation over the year, 
can be compared with the observed number of deaths, and the dif-
ference (the residual) presented as an estimate of excess mortality. 
Since 2009, the network for European monitoring of excess mor-
tality for public health action (EuroMOMO) has monitored weekly 
excess all- cause mortality4, using this method. Using this method, 
excess mortality may be an over- or underestimation of influenza- 
associated mortality, depending on the impact of non- influenza mor-
bidity on mortality during the winter.
To obtain specific estimates of influenza- associated mortality, 
parameters representing influenza activity can be included in a time 
series model, instead of excluding periods with influenza activity 
from the estimation of baseline mortality3,5-7. In this approach, ex-
cess mortality associated with influenza is determined directly from 
influenza activity data and not as a residual, which will also be af-
fected by non- influenza factors.
Within the EuroMOMO network, we developed a model to esti-
mate influenza- associated mortality based on influenza activity in the 
population while controlling for extreme ambient temperatures, the 
FluMOMO model. This model can be used at the national level or at 
the European level to support risk assessment and health planning in 
connection with seasonal influenza epidemics and in a pandemic situ-
ation, and has the potential for timely, in- season use.
The objective of this study was to describe the statistical model, 
FluMOMO, and apply it to estimate influenza- associated mortality in 
Denmark for the seasons 2010/11 to 2016/17.
2  | MATERIAL S AND METHODS
First, we describe the FluMOMO model and consider how the in-
fluenza activity and extreme ambient temperatures variables were 
defined. Secondly, we describe data sources, and finally analytical 
methods.
2.1 | The FluMOMO model
The model is a multivariable time series model with weekly number 
of deaths as dependent variable. We use a multiplicative Poisson re-
gression with overdispersion and ISO- week as time unit. Influenza 
activity (IA) and extreme temperature (ET) are included as independ-
ent variables. The residual variation is post- regression corrected for 
skewness	by	applying	a	⅔-	power	correction8
A general formulation of the regression:
where l is the link function (ie logarithm in a multiplicative model), 
X is the observed number of deaths and t is calendar week. Season- 
year (s) is defined as the period from week 27 to week 26 the fol-
lowing year, and p represents 4 parameters reflecting extreme 
temperature.
The baseline consists of a trend and seasonality ex-
pressed as 2 sine waves of 1 year and half year peri-
ods: sin(2π*t/(365.25/7)) + cos(2π*t/(365.25/7)), sin(2π*t/
((365.25/2)/7)) + cos(2π*t/((365.25/2)/7)), respectively. The sig-
nificance of the trend and the 2 sine waves is tested according to 
predefined levels, see below.
We estimate a separate effect of IA for each season and not for 
the entire period. The rationale for this relates to the fact that the 
type of circulating influenza virus and the match with the influenza 
vaccine will vary from one season to another.
Four parameters (ETt,1 to ETt,4) for ambient temperature were in-
cluded, representing extreme cold in the winter (week 40 to week 20 
the following year), where it may be associated with excess deaths, 
and extreme cold in the summer (week 21- 39), where it may have a 
benign effect. Conversely, periods with extreme heat may be asso-
ciated with excess mortality in the summer but a benign effect in 
the winter.
We include a lag- effect of the explanatory variables, that is, a 
carry- over effect of IA or ET from earlier weeks. Length of the lags 
is predefined as external parameters, and dIA and dET represent the 
delay in the formula.
The model estimates the baseline as well as the effect of IA and 
ET simultaneously, controlled for one another, that is, the baseline 
correlates to IA and ET.
2.1.1 | Expected number of deaths
The expected mean number of deaths including both IA and ET as 
explanatory variables will be
The expected baseline will be
Expected mean number of deaths if only IA or ET had an effect 
will be
Hence, the expected mean excess number of deaths associated 
with IAt and ETt will be (Figure 1):
l(Xt)=β01 ∗baselinet+
∑
dIA
�∑
s β2dIA,s ∗ IAt−dIA,s
�
+
∑
dET
�∑
p β3dET,p ∗ETt−dET,p
�
+εt
E(Xt)=l
−1
[β01 ∗baselinet+
∑
dIA (
∑
s β2,dIA,s ∗ IAt−dIA,s)
+
∑
dET
�∑
p β3,dET,p ∗ETt−dET,p
�
].
E(baselinet)=E(Bt)= l
−1
[β01 ∗baselinet+
∑
dIA (
∑
s β2,dIA,s ∗0)
+
∑
dET (
∑
p β3,dET,p ∗0)].
E(IAt)=l
−1
[β01 ∗baselinet+
∑
dIA (
∑
s β2,dIA,s ∗ IAt−dIA,s)
+
∑
dET (
∑
p β3,dET,p ∗0)]
E(ETt)=l
−1
[β01 ∗baselinet+
∑
dIA (
∑
s β2,dIA,s ∗0)
+
∑
dET (
∑
p β3,dET,p ∗ETt−dET,p)].
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For	post-	estimation	⅔-	power	correction	of	residual	variation	and	
cumulated estimates see Appendix A.
2.2 | Influenza activity (IA)
A commonly used syndromic indicator of IA is the frequency of 
influenza- like illness (ILI), measured for example, through a sentinel 
network of general practitioners (GP). ILI can be expressed as a per-
centage of consultations with ILI (consultation%). If the GPs’ catch-
ment population is known, ILI can be expressed as an incidence. 
Should information on ILI be unavailable, acute respiratory illness 
(ARI) may be used as an alternative indicator.
In Denmark, ILI is reported as the number of ILI consultations 
by age group, but only the total number of consultations. Hence, 
we do not have a denominator for each age group’s consultation%. 
However, assuming consultations have a constant distribution be-
tween age groups through a season, but vary between seasons, 
using the total number of consultations as the denominator in each 
age group, the consultation% in each age group will be propor-
tional to the pattern of the correct consultation% over a specific 
season, thus providing valid estimates of the effect of IA, as the 
effect of IA is estimated separately for each season. Therefore, we 
used the total number of consultations as the denominator for all 
age groups.
Another indicator of IA is the percentage of influenza- positive 
samples (positive%). In Denmark, all influenza samples are registered 
on a personal level, that is, with known age for each person, in a na-
tional centralised database9. For this study, we considered more than 
one sample from the same person, on the same date, as one sample. 
If at least one sample tested positive for influenza, we considered 
the sample as a positive sample independent of the test result of 
other samples taken that day. If a person had a positive sample, then 
all following samples in that season were excluded.
Influenza- like illness may overestimate IA, as other respiratory 
infections may cause ILI. On the other hand, % positive may not fully 
reflect the intensity of IA in the population. Therefore, Goldstein 
et al10,11 suggested using ILI × positive% (Goldstein index) as an in-
dicator of IA.
We applied 3 indicators of IA in the FluMOMO model: ILI consul-
tation%, positive% and the Goldstein index.
2.3 | Extreme ambient temperatures
Danish weather stations register daily average temperature as 
well as daily minimum and maximum temperature. Averages over 
each of these daily temperatures, weighted by the populations 
in the 5 Danish regions, were used as the overall Danish daily 
temperature, and minimum and maximum temperature for that 
day. Weekly temperature as well as weekly minimum and maxi-
mum temperature was calculated as the weekly mean of each of 
the overall daily temperatures, respectively. Using each of these 
mean weekly temperatures, we estimated the expected weekly 
temperature, and expected minimum and maximum temperatures, 
in general linear models with a yearly seasonal variation, fitted as 
a sine wave.
Weeks with extreme temperatures were defined as weeks with 
a mean temperature above the expected maximum temperature or 
below the expected minimum temperature (Figure 2). Nominal val-
ues were defined as how far the observed temperature was below or 
above the expected minimum or maximum.
2.4 | Data sources
2.4.1 | Deaths
Individual notifications of all- cause dates of deaths and dates of 
birth were obtained from the Danish Civil Registry.
2.4.2 | Influenza activity
The Danish sentinel surveillance system for influenza is a voluntary 
system of GPs providing weekly reports (week 40- 20) on the total 
number of consultations and age- specific numbers of ILI consulta-
tions to Statens Serum Institut. Any ILI consultations which took 
place outside of week 40- 20 were set to 0.
Electronic data on all patients swabbed at the general practi-
tioners (GP) or at hospitals and tested for influenza virus by PCR 
were retrieved from the Danish Microbiology Database (MiBa)12, 
where these samples have been registered since 2010.
2.4.3 | Ambient temperatures
Data on daily temperatures registered at Danish weather stations 
was downloaded from the National Oceanic and Atmospheric 
Administration Online Climate Data Directory13.
E(ΔIAt)=E(IAt)−E(Bt)
E(ΔETt)=E(ETt)−E(Bt).
F IGURE  1 Baseline, effect of influenza 
activity and extreme temperature (ET)
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2.4.4 | Population
The size of the Danish population by age at the start of every quarter 
of the year was downloaded from Statistics Denmark14. The weekly 
size of each age group specific population was achieved by linear 
interpolation.
2.5 | Analyses
Analyses were performed separately for the age groups 0- 4, 5- 14, 
15- 64 and 65+ years of age, as well as for all ages.
A fatal outcome after infection with influenza virus will normally 
occur after a time- delay, where co- morbidity and complications may 
contribute. On this basis, we applied a 2 weeks lag for both IA and ET.
We included a trend and a half- yearly cycle if they contributed 
on a 5% level (P < .05), while yearly seasonality was included on a 
10% level.
There may be other changes in mortality over calendar time than 
seasonality. Therefore, a trend is included in the baseline. Long- term 
changes may be modelled using a non- linear trend, for example, a 
spline. However, non- linear trends tend to be less stable at the ends, 
and if we intend to use the model for monitoring, interest will be in 
the ends, especially the right end, which informs the most recent 
impact. As the model potentially can be used for in- season and near 
timely monitoring, we have limited the model to use a linear trend.
When estimating over more than 5 seasons, the linear trend as-
sumption did not always hold (likelihood- ratio test between a spline 
and a linear trend), and including <3 seasons seems to make the fit less 
stable (most estimates become insignificant, because of low statistical 
power). Hence, we used 5 seasons’ estimation periods. Furthermore, 
when estimating results for a season, this must not depend on future 
observations, that is, following seasons, only on the present and pre-
ceding seasons. As we only have complete data from 2010 and on-
wards, using 5 seasons’ estimation periods, results for the seasons 
2010/11 to 2013/14 can only be estimated using data from the 
preceding seasons and should therefore be interpreted with caution. 
We separated the analyses over the period 2010/11 to 2016/17 in 
3 estimation periods. The first estimation period was from 2010/11 
to 2014/15, reporting results for the 2014/15 season and also re-
porting results for the 2010/11 to 2013/14 seasons. The second es-
timation period was from 2011/12 to 2015/16 reporting results for 
the 2015/16 season, and finally the third estimation period was from 
2012/13 to 2016/17, reporting the 2015/16 results.
Weeks with a negative IA- effect were after estimation excluded 
from reported results, in line with a common practice in estimation 
of influenza- associated mortality due to the challenge of interpre-
tation of a non- negative effect of influenza on mortality. However, 
unrestricted results are shown in Appendix B.
All analyses were performed using Stata 14.2 MP. The FluMOMO 
code in Stata and R is freely downloadable from the EuroMOMO 
website (www.EuroMOMO.eu).
3  | RESULTS
During the seasons 2010/11 to 2016/17, around 146 (4.1%) of all 
Danish GPs participated in the sentinel surveillance, and a median of 
15 822 (range 8129- 31 565) samples was tested for influenza virus 
per season. Figure 3 shows the 3 indicators of influenza activity (IA): 
ILI (consultation%), positive% and Goldstein index.
After fitting the model, there were no indications of neither het-
eroscedasticity nor residual autocorrelation. The model had the same 
F IGURE  2 Weekly mean of average 
daily ambient temperatures in Denmark
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level of information criteria (AIC and BIC) across the different IA’s, but 
varied between the age groups. AIC’s for the 4 age groups (0- 4, 5- 14, 
15-	64,	≥65)	and	for	all	ages	were	5.49,	2.66,	8.33,	10.01	and	10.22,	
and	for	BIC	−969.5,	−1015.1,	−983.2,	−954.0	and	−956.53.	The	fit	of	
the model is illustrated in Appendix B (Figure B1). Figure 4 shows the 
outcome of the model, where effects of IA are restricted to be positive. 
The figure shows baseline, mortality rates associated with influenza 
using Goldstein index as IA indicator and mortality rates associated 
with ET over the 5 seasons 2012/13 to 2016/17 used to estimate the 
2016/17 influenza- associated mortality.
Mortality rates varied depending on the IA indicator used, with a me-
dian mortality rate over the seasons 2010/11 to 2016/17 for all ages of 
F IGURE  3 Weekly influenza activity indicators
Virus1:        A(H1N1)             A(H3N2)            A(H3N2)+B            A(H1N1)              A(H2N3)           A(H1N1)+B           A(H3N2) 
Intensity2:   low-medium           low                        high                      low                       low             medium -high            high 
Green: ILI consultation% Red: Positive%   Black: Goldstein index 
1) Dominant influenza virus 2) Intensity of influenza circulation (very low to very high) 
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17.6 (range: 0.0- 36.2) deaths per 100 000 per year using ILI, 14.1 (range: 
0.3- 31.6) using positive% and 8.3 (range: 0.0- 25.0) using Goldstein 
index. These figures correspond to a median of 1104 (range: 2- 2064), 
805 (range: 14- 1771) and 474 (range: 0- 1399) deaths, respectively 
(Table 1). Number of deaths and mortality rates by age group for each of 
the different IA indicators are shown in Table 1 and illustrated in Figure 5.
4  | DISCUSSION
Infection with the influenza virus may often lead to exacerbation of 
underlying chronic conditions or to secondary bacterial infections15. 
Therefore, influenza is often not recorded as the primary cause of 
death, and using cause- specific data as an outcome may lead to 
underestimation of influenza- associated mortality. Furthermore, 
in most countries, cause of death is available with large delays. 
Therefore, timely estimation of influenza- associated mortality 
should be based on all- cause mortality, although this outcome may 
be associated with loss of some specificity. The present work started 
as an initiative within the EuroMOMO network, with the aim of ob-
taining a direct and timely estimation of mortality associated with 
influenza.
In the present study based on Danish data, the model generally 
captures the background seasonal mortality pattern well. However, 
F IGURE  4 All- cause mortality 
rates using the FluMOMO model with 
Goldstein index
     |  597NIELSEN Et aL.
T
A
B
L
E
 1
 
In
flu
en
za
- a
ss
oc
ia
te
d 
m
or
ta
lit
y 
ra
te
s 
ba
se
d 
on
 d
iff
er
en
t i
nf
lu
en
za
 a
ct
iv
ity
 in
di
ca
to
rs
Se
as
on
a
D
ea
th
M
or
ta
lit
yb
D
ea
th
M
or
ta
lit
yb
D
ea
th
M
or
ta
lit
yb
D
ea
th
M
or
ta
lit
yb
D
ea
th
M
or
ta
lit
yb
A
ge
:
A
ll 
ag
es
0-
 4 
ye
ar
s
5-
 14
 y
ea
rs
15
- 6
4 
ye
ar
s
A
ge
d 
65
IL
I (
C
on
su
lta
tio
n 
pe
rc
en
ta
ge
)
20
10
/1
1
11
8
2.
12
 (1
.3
8-
 2.
96
)
7
2.
23
 (0
.4
7-
 4.
70
)
1
0.
19
 (0
.1
9-
 0.
19
)
22
1
6.
09
 (5
.0
9-
 7.
14
)
16
6
17
.5
2 
(1
7.
52
- 1
7.
52
)
20
11
/1
2
49
4
8.
85
 (7
.7
1-
 10
.0
4)
25
7.
88
 (4
.9
5-
 11
.2
3)
0
- 
24
5
6.
78
 (5
.8
6-
 7.
74
)
43
6
44
.3
8 
(3
8-
 36
- 5
0.
69
)
20
12
/1
3
20
64
36
.8
2 
(3
4.
74
- 3
8.
93
)
0
- 
0
- 
32
7
9.
03
 (7
.9
1-
 10
.2
)
17
36
17
1.
94
 (1
61
.3
6-
 18
2.
74
)
20
13
/1
4
2
0.
03
 (0
.0
3-
 0.
03
)
38
12
.6
9 
(8
.6
7-
 17
.1
8)
0
- 
20
6
5.
67
 (4
.7
4-
 6.
65
)
2
0.
15
 (0
.1
5-
 0.
15
)
20
14
/1
5
18
61
32
.8
0 
(3
1.
04
- 3
4.
59
)
14
4.
60
 (2
.3
0-
 7.
38
)
1
0.
09
 (0
.0
9-
 0.
09
)
40
6
11
.1
2 
(1
0.
08
- 1
2.
19
)
15
45
14
5.
78
 (1
37
.1
2-
 15
4.
61
)
20
15
/1
6
10
04
17
.5
6 
(1
6.
06
- 1
9.
10
)
16
5.
32
 (2
.5
1-
 8.
76
)
2
0.
33
 (0
.3
3-
 0.
33
)
19
3
5.
26
 4
.3
4-
 6.
23
)
98
3
90
.7
4 
(8
3.
19
- 9
8.
51
)
20
16
/1
7
12
31
21
.3
8 
(1
9.
86
- 2
2.
96
)
20
6.
56
 (3
.5
6-
 10
- 1
3)
1
0.
22
 (0
.2
2-
 0.
22
)
20
0.
54
 (0
.5
4-
 0.
54
)
11
52
10
4.
49
 (9
6.
39
- 1
12
.3
8)
M
ed
ia
n
10
04
17
.5
6
16
5.
32
1
0.
09
22
1
6.
09
98
3
90
.7
4
Po
si
tiv
e 
pe
rc
en
ta
ge
20
10
/1
1
13
3
2.
38
 (1
.5
8-
 3.
29
)
8
2.
53
 (2
.5
3-
 2.
53
)
13
1.
93
 (1
.0
0-
 3.
04
)
88
2.
43
 (1
.7
0-
 3.
26
)
55
5.
81
 (2
.7
3-
 9.
58
)
20
11
/1
2
14
0.
25
 (0
.2
5-
 0.
25
)
9
2.
82
 (1
.0
3-
 5-
 14
)
3
0.
46
 (0
.0
0-
 1.
24
)
20
0.
56
 (0
.5
6-
 0.
56
)
11
6
11
.7
7 
(8
.2
8-
 15
.6
5)
20
12
/1
3
17
71
31
.5
8 
(2
9.
61
- 3
3.
58
)
10
3.
22
 (1
.1
6-
 5.
88
)
1
0.
10
 (0
.0
0-
 0.
54
)
15
1
4.
17
 (3
.3
4-
 5.
07
)
18
11
17
9.
39
 (1
68
.8
9-
 19
0.
14
)
20
13
/1
4
21
0.
37
 (0
.3
7-
 0.
37
)
37
12
.2
8 
(1
2.
28
- 1
2.
28
)
3
0.
50
 (0
.0
5-
 1.
19
)
44
1.
21
 (1
.2
1-
 1.
21
)
3
0.
27
 (0
.2
7-
 0.
27
)
20
14
/1
5
10
90
19
.2
2 
(1
7.
76
- 2
0.
72
)
2
0.
55
 (0
.5
5-
 0.
55
)
4
0.
66
 (0
.6
6-
 0.
66
)
10
5
2.
87
 (2
.2
1-
 3.
58
)
12
64
11
9.
22
 (1
1.
39
- 1
27
.2
2)
20
15
/1
6
80
5
14
.0
7 
(1
2.
69
- 1
5.
50
)
23
7.
64
 (7
.6
4-
 7.
64
)
2
0.
37
 (0
.0
1-
 0.
99
)
15
4
4.
20
 (3
.3
8-
 5.
08
)
71
9
66
.3
7 
(5
9.
71
- 7
3.
26
)
20
16
/1
7
13
10
22
.7
7 
(2
1.
22
- 2
4.
34
)
48
15
.9
1 
(1
1.
62
- 2
0.
63
)
6
0.
87
 (0
.8
7-
 0.
87
)
51
1.
38
 (0
.8
6-
 1.
98
)
13
47
12
2.
15
 (1
14
.2
6-
 13
0.
22
)
M
ed
ia
n
80
5
14
.0
7
10
3.
22
3
0.
50
88
2.
43
71
9
66
.3
7
G
ol
ds
te
in
 in
de
x
20
10
/1
1
19
0.
34
 (0
.3
4-
 0.
34
)
4
1.
12
 (0
.0
0-
 3.
21
)
9
1.
29
 (0
.4
9-
 2.
32
)
65
1.
80
 (1
.8
0-
 1.
80
)
21
2.
26
 (0
.3
0-
 5.
18
)
20
11
/1
2
39
0.
70
 (0
.2
6-
 1.
28
)
8
2.
44
 (0
.6
4-
 4.
88
)
2
0.
35
 (0
.0
0-
 1.
17
)
47
1.
30
 (0
.7
7-
 1.
92
)
42
4.
28
 (1
.7
7-
 7.
42
)
20
12
/1
3
13
99
24
.9
5 
(2
3.
12
- 2
6.
83
)
1
0.
29
 (0
.0
0-
 1.
90
)
0
0.
07
 (0
.0
0-
 0.
53
)
11
5
3.
17
 (2
.3
8-
 4.
03
)
11
76
11
6.
46
 (1
07
.0
8-
 12
6.
10
)
20
13
/1
4
0
0.
01
 (0
.0
1-
 0.
01
)
24
7.
92
 (7
.9
2-
 7.
92
)
2
0.
34
 (0
.0
0-
 1.
05
)
9
0.
25
 (0
.2
5-
 0.
25
)
1
0.
07
 (0
.0
7-
 0.
07
)
20
14
/1
5
82
2
14
.4
9 
(1
3.
13
- 1
5.
89
)
2
0.
52
 (0
.0
0-
 2.
24
)
5
0.
68
 (0
.6
8-
 0.
68
)
84
2.
29
 (1
.6
6-
 2.
99
)
72
4
68
.2
6 
(6
1.
52
- 7
5.
23
)
20
15
/1
6
47
4
8.
29
 (7
.1
4-
 9.
50
)
12
4.
21
 (1
.6
6-
 7.
45
)
2
0.
29
 (0
.2
9-
 0.
29
)
10
7
2.
92
 (2
.1
9-
 3.
72
)
41
6
38
.3
9 
(3
2.
7-
 44
.3
8)
20
16
/1
7
75
1
13
.0
4 
(1
1.
75
- 1
4.
38
)
36
12
.1
4 
(8
.1
8-
 16
.6
0)
1
0.
08
 (0
.0
8-
 0.
08
)
17
0.
46
 (0
.4
6-
 0.
46
)
76
7
69
.5
4 
(6
2.
77
- 7
6.
53
)
M
ed
ia
n
47
4
8.
29
8
2.
44
2
0.
34
65
1.
8
41
6
38
.3
9
a S
ea
so
n:
 w
ee
k 
40
 to
 w
ee
k 
20
 th
e 
fo
llo
w
in
g 
ye
ar
.
b D
ea
th
s 
pe
r 1
00
 0
00
 p
er
 y
ea
r (
95
%
 c
on
fid
en
ce
 in
te
rv
al
).
598  |     NIELSEN Et aL.
for some weeks, the estimated effect of IA was negative. For small, 
insignificant negative effects, this will be within the statistical vari-
ation. A decision to exclude these weeks will cause a slight over-
estimation of influenza- associated mortality. However, negative 
effects that are statistically significant or seen over a long period 
may indicate a problem with a poor fit of the model, for example 
if the baseline is too high. Presently, there is no proper solution 
to this problem, which warrants more attention. From a biological 
standpoint, a negative effect of influenza can be interpreted as a 
“protective effect,” which is implausible. To overcome this, many 
modellers present negative values as a nought3,16. Along these lines, 
we excluded weeks with negative values from influenza- associated 
mortality. This choice is convenient because it facilitates dissemi-
nation of a public health message of influenza- associated mortality, 
but it warrants a more critical review. The effect of excluding weeks 
with negative effects of IA is shown in appendix B, showing results 
without this restriction.
Other respiratory pathogens are not directly included in the 
model, even though they may affect winter mortality. If they should 
be included in the model, care has to be taken to avoid collinearity, 
in particular when lags are included, as a lagged effect of one patho-
gen may be confounded by a direct impact of another pathogen5,15. 
Additionally, if included in the model, potential interactions may 
complicate the model and blur the estimates. However, this should 
not prevent further investigation.
Another factor of importance in the seasonal variation in mortal-
ity is ambient temperature or more precisely deviation from expected 
temperature, for example, cold snaps in the winter or heat waves in 
the summer17,18. We have controlled influenza- associated mortality 
for temperature, but the pattern of the effect of temperature on 
F IGURE  5  Influenza activity 
associated winter (week 40 to week 20 
the following year) mortality rates using 
the FluMOMO model
Virus1:         A(H1N1)              A(H3N2)             A(H3N2)+B            A(H1N1)              A(H2N3)             A(H1N1)+B           A(H3N2) 
Intensity2:   low-medium              low                       high                      low                       low                  medium-high           high 
Green: ILI consultation% Red: Positive%   Black: Goldstein index 
1) Dominant influenza virus 2) Intensity of influenza circulation (very low to very high) 
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mortality has to be investigated further to be able to report valid 
estimates of this effect.
We estimated Danish influenza- associated mortality using 3 in-
dicators of influenza activity (Table 1 and Figure 5). All 3 indicators 
show a similar pattern. ILI possibly overestimates influenza mortality 
as ILI may be caused by other respiratory pathogens. Using posi-
tive% as indicator for IA will reduce the effect of other respiratory 
pathogens, but may not, as ILI, reflect the dynamic in the population. 
A combination of the 2, the Goldstein index, will reflect both the dy-
namic of transmission and limit overestimation due to other patho-
gens10,11. Mortality associated with influenza based on the Goldstein 
index seems to be the most appropriate for Danish data, primarily 
because it is conservative. Using the Goldstein index, we found a me-
dian influenza- associated mortality rate of 8.2 per 100 000 popula-
tion which is substantially lower—and probably more realistic—than 
a previous applied methodology that obtained a median mortality of 
26 per 100 000 in the period 1994- 201019. Though, the introduction 
of free vaccinations for elderly and risk groups may have contributed 
to this decline. However, this should be evaluated further including 
data from other EuroMOMO countries.
The Danish influenza data have 2 limitations. It is voluntary for 
GPs to participate in the reporting of ILI, and the distribution of GP’s 
participating is not random. Secondly, sampling of influenza testing 
may be biased towards more samples taken at hospitals, and there-
fore may overestimate the population positive%. These limitations 
in ILI and positive% will introduce some uncertainty in the Goldstein 
index. However, we observed no bias in the estimated effects that 
may have been due to this.
The influenza season 2010/11, the first after the 2009/10 pan-
demic, was dominated by influenza A(N1H1)pdm09 with low to me-
dium intensity20, and very low influenza- associated mortality, except 
for children 5- 14 year of age, corroborating the observation from the 
early waves of the pandemic21. The season 2011/12 was exceptional 
with a very low influenza A(H3N2) activity and low mortality for all 
ages, even though there was significant activity in parts of Europe 
including Norway and Sweden22. In the season 2012/13, Denmark 
experienced a long period with high influenza activity dominated by 
A(H3N2), but also B by the end of the season23. The outcome was 
a marked excess influenza mortality among the elderly. Influenza 
activity and mortality were low in the A(H1N1) dominated 2013/14 
season, although raised among children below 5 years of age24. In the 
following season, 2014/15, A(H3N2) influenza started to circulate 
late with low intensity. However, many patients received intensive 
care, and mortality was high among the elderly25,26. In the rather long 
2015/16 season, influenza first came as A(N1H1)pdm09 and was fol-
lowed by B. Intensity was relative high and many patients received 
intensive care27. Mortality was moderately raised in all ages, higher 
than the previous A(H1N1) seasons, also among the elderly. The later 
could be due to influenza B. The 2016/17 A(H3N2) dominated season 
started early giving a long season, with a high intensity. The number of 
influenza- related admissions was the highest since 2010/11, but with 
relatively few patients receiving intensive care28. Mortality was high 
among the elderly.
We present a time series model, the FluMOMO model, with 
the aim of estimating mortality associated with influenza, and 
thereby contributing to the need for severity assessment of in-
fluenza. We used all- cause mortality as the outcome, because all- 
cause mortality data are readily available in most countries and 
have previously been found to be applicable for assessing the total 
impact of influenza on mortality15. The model fitted well, but was 
subject to some limitations, including the handling of negative es-
timates, that should be further investigated. The parametrisation 
of the effect of extreme temperatures should be further devel-
oped to provide robust estimates of excess mortality associated 
with extreme temperatures.
The 3 indicators of IA, ILI (consultation%), positive% and 
Goldstein index, showed similar patterns. We recommend the 
Goldstein index, because it provided conservative estimates, and 
is a more valid representation of influenza activity than indica-
tors from syndromic surveillance (ILI/ARI) or laboratory indica-
tors that do not encompass information about circulation in the 
community.
We have shown than FluMOMO has the potential to provide 
robust and standardised seasonal estimates of mortality associated 
with influenza. Furthermore, if data are available, the model may 
also provide in- season estimates. One of the challenges with timely 
estimates is the delay in registration. The EuroMOMO algorithm in-
cludes a compensation for delay in registration of deaths. Hence, 
countries participating in the EuroMOMO network can use these 
delay- adjusted numbers of deaths. This implies that the FluMOMO 
model potentially can provide timely estimates of influenza- 
associated mortality, depending on timeliness of the influenza indi-
cators (ILI and positive%).
In conclusion, the FluMOMO can be used to model the impact of 
influenza on mortality in almost real time, and we encourage to in-
clude the FluMOMO model as a tool in “the toolbox of influenza sur-
veillance,” in particular to support severity assessment. Meanwhile, 
the model, including the use of different IA indicators, should be 
further evaluated.
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APPENDIX A
POS T-  E S TIMATION ⅔-  POWER CORREC TION OF RE-
SIDUAL VARIANCE
Formulation	 of	 the	 ⅔-	power	 variance	 corrected	 residual	 variance	
(RVar), that is, the uncertainty or confidence intervals of the esti-
mated mean effects:
Using	the	delta-	method,	the	residual	⅔-	power	variances	of	∆IAt or 
∆ETt becomes
where E(Bt) is the estimated baseline number of deaths and E(IAt) is 
the expected number of deaths had the effect of ETt been zero. 
Var(E(Bt)) and Var(E(IAt)) are the regression variances. However, in a 
regression with a link function l, these are “only” known at the l- 
scale. Using the link function log, as we do, the regression variance 
become
where Varlog(E(Xt)) is the regression variance on the log- scale. Hence
and likewise for ETt:
Confidence intervals are then calculated as:
where Xt may be IA or ET, respectively.
CUMUL ATED NUMBER OF E XCE SS DE ATHS
The mean cumulated excess number of deaths over s weeks will be
Assuming independence between weeks, that is, no residual 
autocorrelation,	 then	 the	 ⅔-	power	 variance	 corrected	 residual	
variance of the cumulated excess deaths over s weeks will be
Confidence intervals are then calculated as:
where EB is baseline and Xt may be IA or ET, respectively.
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APPENDIX B
F IGURE  B1 . All- cause mortality 
rates using the FluMOMO model with 
Goldstein index, where life- saving effects 
of IA are included
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Green: ILI consultation%  Red: Positive%   Black: Goldstein index 
Figure B2. Influenza activity associated winter (week 40 to week 20 the following year) mortality rates using the FluMOMO model
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TABLE  B1  Influenza- associated mortality rates based on different influenza activity (IA) indicators, where life- saving effects of IA have 
not been excluded
Seasona Death Mortalityb Death Mortalityb Death Mortalityb Death Mortalityb Death Mortalityb
Age: All ages 0- 4 years 5- 14 years 15- 64 years Aged 65
ILI (Consultation percentage)
2010/11 33 0.60 (0.16 to 
1.19)
−7 −2.22	(−4.69	
to	−0.47)
−10 −1.53	(−2.65	
to	−0.64)
219 6.05 (5.05 to 
7.10)
149 15.72 (11.26 to 
20.65)
2011/12 445 7.97 (6.87 to 
9.12)
25 7.75 (4.84 to 
11.09)
−20 −3.04	(−4.15	
to	−2.04)
242 6.68 (5.76 to 
7.63)
409 41.66 (35.77 to 
47.84)
2012/13 2064 36.82 (34.74 
to 38.93)
−24 −7.60	(−11.03	
to	−4.61)
−22 −3.32	(−4.62	
to	−2.18)
327 9.03 (7.91 to 
10.20)
1736 171.94 (161.36 
to 182.74)
2013/14 −166 −2.94	(−3.84	
to	−2.12)
37 12.26 (8.30 to 
16.71)
−15 −2.27	(−3.44	
to	−1.27)
205 5.63 (4.70 to 
6.61)
−302 −29.11	(−34.87	
to	−23.71)
2014/15 1861 32.80 (31.04 
to 34.59)
−4 −1.38	(−3.40	
to	−0.10)
−16 −2.47	(−3.92	
to	−1.25)
406 11.11 (10.07 
to 12.18)
1545 145.78 (137.12 
to 154.61)
2015/16 1004 17.55 (16.05 
to 19.09)
16 5.32 (2.51 to 
8.75)
0 −0.06	(−0.53	
to 0.21)
193 5.26 (4.24 to 
6.23)
983 90.74 (83.19 to 
98.51)
2016/17 1231 21.38 (19.86 
to 22.94)
18 6.07 (3.16 to 
9.56)
−2 −0.25	(−0.94	
to 0.06)
−70 −1.89	(−2.57	
to	−1.29)
1152 104.49 (96.79 
to 112.38)
Median 1004 17.55 16 5.32 −15 2.27 219 6.05 983 90.74
Positive percentage
2010/11 −323 −5.81	(−7.00	
to	−4.69)
−3 −0.93	(−2.89	
to 0.04)
13 1.92 (0.99 to 
3.03)
6 0.18	(−0.02	
to 0.59)
−67 −7.07	(−11.06	
to	−373)
2011/12 −169 −3.03	(−3.91	
to	−2.23)
4 1.12 (0.03 to 
2.95)
−1 −0.11	(−0.70	
to 0.20)
−55 −1.52	(−2.13	
to	−0.98)
71 7.27 (4.67 to 
10.63)
2012/13 1767 31.51 (29.54 
to 33.51)
−12 −3.81	(−6.60	
to	−1.59)
−3 −0.43	(−1.02	
to	−0.05)
138 3.80 (2.99 to 
4.67)
1811 179.39 (168.86 
to 190.14)
2013/14 −332 −5.89	(−6.99	
to	−4.86)
35 11.55 (7.72 to 
15.86)
2 0.24	(−0.04	
to 0.83)
28 0.78 (0.35 to 
1.30)
−129 −12.44	(−16.70	
to	−8.63)
2014/15 1086 19.14 (17.68 
to 20.63)
−3 −1.17	(−3.05	
to	−0.04)
4 0.56 (0.16 to 
1.10)
94 2.58 (1.94 to 
3.27)
1263 119.16 (11.33 
to 127.16)
2015/16 805 14.07 (12.69 
to 15.50)
9 3.19 (0.95 to 
6.19)
0 −0.04	(−0.46	
to 0.21)
153 4.17 (3.35 to 
5.04)
718 66.31 (59.65 to 
73.19)
2016/17 1308 22.72 (21.18 
to 24.30)
47 15.75 (11.48 
to 20.45)
1 0.19	(−0.07	
to 0.76)
−53 −1.42	(−2.03	
to	−0.89)
1337 121.25 (113.38 
to 129.30)
Median 805 14.07 4 1.12 1 0.19 28 0.78 718 66.31
Goldstein index
2010/11 −406 −7.30	(−854	
to	−6.13)
−6 −1.80	(−4.15	
to	−0.23)
8 1.24 (0.45 to 
2.25)
−5 −0.13	(−0.53	
to 0.05)
−324 −34.12	(−40.49	
to	−28.12)
2011/12 −276 −4.94	(−5.96	
to	−3.99)
1 0.35	(−0.43	to	
1.96)
0 0.02	(−0.38	
to 0.57)
−36 −0.98	(−1.55	
to	−0.51)
−204 −20.79	(−25.81	
to	−16.15)
2012/13 1399 25.95 (23.12 
to 26.83)
−18 −5.85	(−9.06	
to	−3.15)
−2 −0.28	(−0.89	
to 0.01)
115 3.17 (2.38 to 
4.03)
1176 116.46 (107.08 
to 126.10)
2013/14 −308 −5.46	(−6.55	
to	−4.43)
23 7.75 (4.21 to 
11.94)
1 0.13	(−0.15	
to 0.72)
5 0.15	(−0.03	
to 0.52)
−339 −32.72	(−38.61	
to	−21.16)
2014/15 822 14.49 (13.13 
to 15.89)
1 0.23	(−0.56	to	
1.73)
2 0.38 (0.00 to 
1.07)
72 1.98 (1.38 to 
2.64)
724 68.26 (61.52 to 
75.23)
2015/16 474 8.29 (7.14 to 
9.50)
8 2.70 (0.62 to 
5.58)
0 −0.07	(−0.57	
to 0.20)
106 2.89 (2.16 to 
2.68)
416 38.39 (32.70 to 
44.38)
2016/17 751 13.04 (11.75 
to 14.38)
36 12.06 (8.10 to 
16.50)
0 −0.03	(−0.49	
to 0.28)
−72 −1.95	(−2.63	
to	−1.35)
767 68.54 (62.77 to 
76.53)
Median 474 8.29 1 0.35 0 0.02 5 0.15 416 38.39
aSeason: week 40 to week 20 the following year.
bDeaths per 100 000 per year (95% confidence interval).
